Financial Ratios | Glaxosmithkline Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2570.8511.2 (+0.44 %)
PREV CLOSE (Rs.) 2559.65
OPEN PRICE (Rs.) 2550.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8364
TODAY'S LOW / HIGH (Rs.)2550.30 2619.25
52 WK LOW / HIGH (Rs.)1376.5 2759
NSE2570.7021.1 (+0.83 %)
PREV CLOSE( Rs. ) 2549.60
OPEN PRICE (Rs.) 2545.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2570.70 (94)
VOLUME 119202
TODAY'S LOW / HIGH(Rs.) 2540.60 2619.90
52 WK LOW / HIGH (Rs.)1377.25 2760

Financial Ratios

Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)34.8336.05100.0421.145.50
   CEPS(Rs)38.9439.7526.5021.6010.38
   DPS(Rs)32.0032.0090.0030.0040.00
   Book NAV/Share(Rs)105.47102.89157.1987.26107.47
   Tax Rate(%)27.7227.3551.1236.7269.52
Margin Ratios
   Core EBITDA Margin(%)26.3124.7321.2019.1419.55
   EBIT Margin(%)23.6825.7821.7314.649.28
   Pre Tax Margin(%)23.6325.7221.6714.539.09
   PAT Margin (%)17.0818.6910.599.192.77
   Cash Profit Margin (%)19.1020.7112.4911.715.23
Performance Ratios
   ROA(%)17.8715.7610.119.521.72
   ROE(%)33.4327.5818.3917.424.71
   ROCE(%)46.4938.0637.7227.7415.76
   Asset Turnover(x)1.050.840.951.040.62
   Sales/Fixed Asset(x)5.255.316.033.043.34
   Working Capital/Sales(x)2.712.781.794.684.47
Efficiency Ratios
   Fixed Capital/Sales(x)0.190.190.170.330.30
   Receivable days21.9022.3221.3718.4211.96
   Inventory Days52.0555.8254.9160.1452.62
   Payable days144.03143.05140.69119.53106.45
Valuation Parameters
   PER(x)55.8036.7316.6268.13226.34
   PCE(x)49.9033.3162.7566.69119.94
   Price/Book(x)18.4212.8710.5816.5111.59
   Yield(%)1.652.425.412.083.21
   EV/Net Sales(x)9.226.547.847.946.21
   EV/Core EBITDA(x)30.8923.5130.6732.8027.18
   EV/EBIT(x)38.9425.3832.8950.8064.12
   EV/CE(x)17.9212.225.687.7210.99
   M Cap / Sales9.536.908.598.346.54
Growth Ratio
   Net Sales Growth(%)6.21-0.8012.05-9.273.08
   Core EBITDA Growth(%)13.968.0318.19-3.744.71
   EBIT Growth(%)-2.417.3270.7146.60-54.32
   PAT Growth(%)-2.9159.5832.55208.21-79.07
   EPS Growth(%)-3.39-63.97373.19284.26-79.07
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)1.841.882.181.491.74
   Quick Ratio(x)1.491.531.871.091.26
   Interest Cover(x)454.77462.54391.29129.5649.26
   Total Debt/Mcap(x)0.000.000.00